Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gerson D Hernandez, MD, MPH
University of Arizona
Study Director - Lon Schneider, MD
University of Southern California
Principal Investigator - Roberta D Brinton, PhD
University of Arizona
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Perseverance Research Center
Scottsdale, Arizona, United States
- University of Arizona / Clinical & Translational Sciences Research Center
Tucson, Arizona, United States
- Atp Clinical Research
Costa Mesa, California, United States
- Syrentis Clinical Research
Santa Ana, California, United States
- Miami Jewish Health
Miami, Florida, United States
- Optimus U Corporation
Miami, Florida, United States
- Combined Research Orlando
Orlando, Florida, United States
- Conquest Research
Winter Park, Florida, United States
- Medvadis Research
Waltham, Massachusetts, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Aug 2023
- Primary completion
- 18 Nov 2026
- Completion
- 18 Mar 2027
- Last update posted
- 30 Jun 2026
- Registered enrollment
- 100
- Registry id
- NCT04838301
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.